Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6BQT

Complex of 14-3-3 theta with an IRSp53 peptide doubly-phosphorylated at T340 and T360

Summary for 6BQT
Entry DOI10.2210/pdb6bqt/pdb
Related6BCR 6BCY
Descriptor14-3-3 protein theta, Insulin receptor substrate protein of 53 kDa, peptide (IRSp53), 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL, ... (10 entities in total)
Functional Keywordsphosphate binding protein, protein complex, cytoskeleton regulation, cell motility, signaling protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains12
Total formula weight240310.84
Authors
Kast, D.J.,Dominguez, R. (deposition date: 2017-11-28, release date: 2018-12-05, Last modification date: 2024-10-30)
Primary citationKast, D.J.,Dominguez, R.
Mechanism of IRSp53 inhibition by 14-3-3.
Nat Commun, 10:483-483, 2019
Cited by
PubMed Abstract: Filopodia are precursors of dendritic spines and polarized cell migration. The I-BAR-domain protein IRSp53 is a key regulator of filopodia dynamics that couples Rho-GTPase signaling to cytoskeleton and membrane remodeling, playing essential roles in neuronal development and cell motility. Here, we describe the structural-functional basis for 14-3-3-dependent inhibition of IRSp53. Phosphoproteomics, quantitative binding and crystallographic studies demonstrate that 14-3-3 binds to two pairs of phosphorylation sites in IRSp53. Using bicistronic expression, we obtain an IRSp53 heterodimer in which only one subunit is phosphorylated, and show that each subunit of IRSp53 independently binds one 14-3-3 dimer. A FRET-sensor assay using natively phosphorylated IRSp53 reveals opposite conformational changes upon binding of activatory (Cdc42, Eps8) or inhibitory (14-3-3) inputs. Finally, we show that 14-3-3 inhibits IRSp53 binding to membranes. Collectively, our findings support a mechanism whereby phosphorylation-dependent inhibition of IRSp53 by 14-3-3 counters membrane binding and interactions with Cdc42 and downstream cytoskeletal effectors.
PubMed: 30696821
DOI: 10.1038/s41467-019-08317-8
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

227344

数据于2024-11-13公开中

PDB statisticsPDBj update infoContact PDBjnumon